Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.3.1.21 (
CPT
)
4,580
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The study of diabetic
polyneuropathy
is complicated by a lack of clear definitions and the absence of a simple reliable test procedure. Recently, a new sensory perception testing device has been introduced for detection of thresholds for electrical stimuli (current perception:
CPT
) at different frequencies (Neurometer). We compared standardized clinical examination scores with measurements of vibratory perception threshold (VPT) and
CPT
(foot) and obtained reproducibility figures. Participants in the study were healthy controls (H, n = 33), diabetic patients without clinical signs of neuropathy (DN-, n = 23), diabetics with overt diabetic neuropathy (DN+, n = 22), and patients with a diabetes duration of over 20 years (D20, n = 38). As expected, there were highly significant differences (Wilcoxon) in
CPT
, VPT and neurological scores between H/DN- and DN+ (p < 0.001), but not between H and DN-. Correlation between
CPT
and total as well as partial (reflecting small and large fibre functions) neurological examination score were highest at 2000 Hz (r = 0.88); no advantage of lower frequency
CPT
could be identified.
CPT
seemed rather insensitive in detecting neuropathy. Correlations between
CPT
and VPT were only moderate and maximal at 2000 Hz (r = 0.61). Reproducibility of
CPT
was good at 2000 Hz (coefficient of variation 13.3-20.2%), but moderate to poor at lower frequencies (ranging to 62%). We conclude that
CPT
and VPT quantitative sensory testing is only of limited value, mainly because of high variability and poor reproducibility.
...
PMID:Comparison of clinical examination, current and vibratory perception threshold in diabetic polyneuropathy. 820 23